Scientific Sessions 2024  /  Preserving Target Organ Health During Blood Pressure Control: Challenges and Triumphs  /  Targeting the endothelin system in hypertension
Logo

American Heart Association

  2
  0

Final ID:

Targeting the endothelin system in hypertension

  • Clozel, Martine  ( IDORSIA PHARMACEUTICALS LTD. , Allschwil , Switzerland )
  • Sidharta, Patricia  ( IDORSIA PHARMACEUTICALS LTD. , Allschwil , Switzerland )
  • Pollock, David  ( University of Alabama at Birmingham , Birmiham , Alabama , United States )
    • Author Disclosures:
    Martine Clozel: DO have relevant financial relationships ; Ownership Interest:Idorsia Pharmaceuticals Ltd:Active (exists now) ; Individual Stocks/Stock Options:Idorsia Pharmaceuticals Ltd:Active (exists now) ; Employee:Idorsia Pharmaceuticals Ltd:Active (exists now) | Patricia Sidharta: No Answer | David Pollock: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Preserving Target Organ Health During Blood Pressure Control: Challenges and Triumphs

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
How SLTG2 inhibition protects the kidneys and heart

Rinschen Markus, Vallon Volker

Mechanistic impact of environmental determinants on hypertension and cardiovascular disease risk

Rios Francisco, Montezano Augusto

More abstracts from these authors:
Is aprocitentan also sympatholytic in patients with resistant hypertension?

Clozel Martine, Sassi-sayadi Mouna, Dreier Roland

Mechanisms of Endothelin, ETA and ETB Receptors in Hypertension

Pollock David

You have to be authorized to contact abstract author. Please, Login
Not Available